Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04448002 · ClinicalTrials.gov registry record · NA

AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma

A NA study of Asthma, sponsored by University of Florida.

Active
Registry status
NA
Development phase
320
Enrollment target
2
Study locations

NCT04448002 is a NA study of Asthma that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 320 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04448002, a NA study of Asthma, is active but no longer recruiting, sponsored by University of Florida.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
2
Study locations

Study Summary

The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

Conditions Studied

Interventions

  • BEHAVIORAL AIM2ACT
  • BEHAVIORAL mHealth Attention Control Condition

Study Locations (2)

Florida

  • UF Health Pediatrics - Gainesville
  • Nemours Children's Hospital - Jacksonville

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2021-04-23
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04448002

The ClinicalTrials.gov registry entry for NCT04448002 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which AIM2ACT is the first listed.

NCT04448002 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04448002 about?

NCT04448002 is a clinical study titled "AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma". The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver

What is the current status of trial NCT04448002?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2021-04-23. Estimated completion is 2026-03-31.

What conditions does trial NCT04448002 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT04448002?

The interventions under investigation include: AIM2ACT (BEHAVIORAL), mHealth Attention Control Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT04448002?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04448002 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.